AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimyzorb M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Fujin Kami Pharmaceutico

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimyzorb M 1mg/500mg Tablet

DiaBeta Duo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer DiaBeta Duo with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and carry a quick-acting glucose source. Alcohol consumption increases hypoglycemia risk and should be minimized. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your physician prior to use, as it may be unsuitable. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Glimyzorb M 1mg/500mg Tablet

There is no text provided to rephrase.

Uses of Glimyzorb M 1mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glimyzorb M 1mg/500mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Glimyzorb M 1mg/500mg tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.

Common Side effects of Glimyzorb M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimyzorb M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glimyzorb M 1mg/500mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Glimyzorb M 1mg/500mg Tablet works:

Glimyzorb M, a 1mg/500mg tablet, combines the antidiabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimyzorb M 1mg/500mg tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glimyzorb M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glimyzorb M 1mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glimyzorb M 1mg/500mg tablets, as dosage modification may be necessary. Consult your physician for guidance. Glimyzorb M 1mg/500mg tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimyzorb M 1mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Glimyzorb M 1mg/500mg Tablet :

Should you forget a Glimyzorb M 1mg/500mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimyzorb M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimyzorb M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication. Keep it out of reach of children, pets, and others.
Glimyzorb M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency involving excess blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue use and seek immediate medical attention.
Glimyzorb M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood sugar control when used with a healthy diet and regular exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimyzorb M 1mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Glimyzorb M 1mg/500mg Tablet use can lead to Vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental Vitamin B12 intake, at least annually, is recommended by some researchers.
Glimyzorb M 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimyzorb M 1mg/500mg tablets with alcohol is unsafe. Alcohol can exacerbate the medication's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimyzorb M 1mg/500mg Tab...
92
MRP 106
13% off